1. Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma
   Mohammed I. Khan et al, 2018, BMC Cancer CrossRef
2. Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators
   Mellar P. Davis, 2022, Cannabis and Cannabinoid-Based Medicines in Cancer Care CrossRef
3. Cannabinoids in the landscape of cancer
   Nagina Mangal et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
4. Synthetic Cannabinoid Agonist WIN 55212-2 Targets Proliferation, Angiogenesis, and Apoptosis via MAPK/AKT Signaling in Human Endometriotic Cell Lines and a Murine Model of Endometriosis
   Harshavardhan Lingegowda et al, 2021, Frontiers in Reproductive Health CrossRef
5. Molecular Mechanism of Cannabinoids in Cancer Progression
   Cristina Pagano et al, 2021, International Journal of Molecular Sciences CrossRef
6. Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges
   Mansab Ali Saleemi et al, 2022, Pharmaceuticals CrossRef
7. WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner
   Antonietta Notaro et al, 2019, International Journal of Molecular Sciences CrossRef
8. Medical Use of Cannabinoids
   Ana Isabel Fraguas-Sánchez et al, 2018, Drugs CrossRef
9. The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects
   Fatemeh Hosami et al, 2021, Biomedicine & Pharmacotherapy CrossRef
10. Cannabinoids Induce Cell Death and Promote P2X7 Receptor Signaling in Retinal Glial Progenitors in Culture
    Hércules Rezende Freitas et al, 2019, Molecular Neurobiology CrossRef
11. Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells
    Meng-Wei Ko et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
12. WIN55,212-2 induces caspase-independent apoptosis on human glioblastoma cells by regulating HSP70, p53 and Cathepsin D
    Ana Gabriela Silva et al, 2019, Toxicology in Vitro CrossRef
13. The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization
    Astrid Coronado-Álvarez et al, 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef
14. The evolution of cannabinoid receptors in cancer
    Nakea M. Pennant et al, 2023, WIREs Mechanisms of Disease CrossRef
15. Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models
    Paula Morales et al, 2021, Cannabinoids and Neuropsychiatric Disorders CrossRef
16. Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics
    Rui Filipe Malheiro et al, 2023, Pharmacological Research CrossRef
17. Cannabinoid WIN 55,212‐2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid‐receptor 2 dependent manner
    Domenica Roberto et al, 2019, The Prostate CrossRef
18. Antitumor Cannabinoid Chemotypes: Structural Insights
    Paula Morales et al, 2019, Frontiers in Pharmacology CrossRef
19. TIBBİ KENEVİR VE SAĞLIK: FARMAKOLOJİK BİR DERLEME
    Özge BALPINAR NALCI et al, 2021, Ankara Universitesi Eczacilik Fakultesi Dergisi CrossRef
20. Disorders of cancer metabolism: The therapeutic potential of cannabinoids
    Dingya Sun et al, 2023, Biomedicine & Pharmacotherapy CrossRef
21. Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells
    Özge Boyacıoğlu et al, 2022, Cell Biology and Translational Medicine, Volume 19 CrossRef